These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 16759090

  • 1. Refining the multiple protein structure pharmacophore method: consistency across three independent HIV-1 protease models.
    Meagher KL, Lerner MG, Carlson HA.
    J Med Chem; 2006 Jun 15; 49(12):3478-84. PubMed ID: 16759090
    [Abstract] [Full Text] [Related]

  • 2. Incorporating protein flexibility in structure-based drug discovery: using HIV-1 protease as a test case.
    Meagher KL, Carlson HA.
    J Am Chem Soc; 2004 Oct 20; 126(41):13276-81. PubMed ID: 15479081
    [Abstract] [Full Text] [Related]

  • 3. Exploring experimental sources of multiple protein conformations in structure-based drug design.
    Damm KL, Carlson HA.
    J Am Chem Soc; 2007 Jul 04; 129(26):8225-35. PubMed ID: 17555316
    [Abstract] [Full Text] [Related]

  • 4. Parallel screening and activity profiling with HIV protease inhibitor pharmacophore models.
    Steindl TM, Schuster D, Laggner C, Chuang K, Hoffmann RD, Langer T.
    J Chem Inf Model; 2007 Jul 04; 47(2):563-71. PubMed ID: 17381173
    [Abstract] [Full Text] [Related]

  • 5. 3D-QSAR studies on chromone derivatives as HIV-1 protease inhibitors: application of molecular field analysis.
    Nunthanavanit P, Anthony NG, Johnston BF, Mackay SP, Ungwitayatorn J.
    Arch Pharm (Weinheim); 2008 Jun 04; 341(6):357-64. PubMed ID: 18442018
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combinatorial design of nonsymmetrical cyclic urea inhibitors of aspartic protease of HIV-1.
    Frecer V, Burello E, Miertus S.
    Bioorg Med Chem; 2005 Sep 15; 13(18):5492-501. PubMed ID: 16054372
    [Abstract] [Full Text] [Related]

  • 12. Structure-based QSAR analysis of a set of 4-hydroxy-5,6-dihydropyrones as inhibitors of HIV-1 protease: an application of the receptor-dependent (RD) 4D-QSAR formalism.
    Santos-Filho OA, Hopfinger AJ.
    J Chem Inf Model; 2006 Sep 15; 46(1):345-54. PubMed ID: 16426069
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Targeting the open-flap conformation of HIV-1 protease with pyrrolidine-based inhibitors.
    Böttcher J, Blum A, Dörr S, Heine A, Diederich WE, Klebe G.
    ChemMedChem; 2008 Sep 15; 3(9):1337-44. PubMed ID: 18720485
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. BREED: Generating novel inhibitors through hybridization of known ligands. Application to CDK2, p38, and HIV protease.
    Pierce AC, Rao G, Bemis GW.
    J Med Chem; 2004 May 20; 47(11):2768-75. PubMed ID: 15139755
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. How inaccuracies in protein structure models affect estimates of protein-ligand interactions: computational analysis of HIV-I protease inhibitor binding.
    Thorsteinsdottir HB, Schwede T, Zoete V, Meuwly M.
    Proteins; 2006 Nov 01; 65(2):407-23. PubMed ID: 16941468
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.